Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
SLGL
#3630
Sol-Gel Technologies Ltd. - Ordinary Shares
69.5
2
USD
+0.01%
Market Price
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
+0.61%
Monthly Change
-16.51%
6 month change
-22.32%
Year Change
+195.83%
Previous Close
69.1
0
Open
69.5
2
Low
69.5
2
High
69.5
2
Volume
5
Markets
US Stock Market
Healthcare
Biotechnology
SLGL
1D
1W
1M
3M
6M
YTD
1Y
5Y
Open full chart
Financials
Overview
Statement
Statistics
Documents
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q4, 25
Total assets
29.92 M
Total liabilities
7.11 M
Total equity
22.81 M
Total liabilities & shareholders' equities
29.92 M
Total debt
—
Net debt
—
News
MeiraGTx Holdings PLC (MGTX) Q2 Earnings and Revenues Surpass Estimates
Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue Estimates
Supernus Pharmaceuticals (SUPN) Matches Q2 Earnings Estimates
Bausch Health (BHC) Q2 Earnings and Revenues Beat Estimates
Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates
Sol-Gel Technologies Ltd. (SLGL) Reports Q4 Loss, Misses Revenue Estimates
Sol Gel Technologies stock price target raised to $110 from $50 at H.C. Wainwright
Sol-Gel Technologies: Downgrading To 'Hold' As Success Relies On Q4 Catalyst (SLGL)
Why Is Small Cap Sol-Gel Tech Stock Falling Today? - Sol-Gel Technologies (NASDAQ:SLGL)
Sol-Gel halts Darier disease treatment after failed clinical trial
Opaleye management buys Sol-Gel Technologies (SLGL) shares
Sol Gel Tech earnings missed by $1.25, revenue fell short of estimates